vs

Side-by-side financial comparison of CPS TECHNOLOGIES CORP (CPSH) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $8.2M, roughly 1.6× CPS TECHNOLOGIES CORP). CPS TECHNOLOGIES CORP runs the higher net margin — 0.2% vs -73.9%, a 74.0% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 38.3%). CPS TECHNOLOGIES CORP produced more free cash flow last quarter ($-487.0K vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 17.8%).

Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

CPSH vs TLSI — Head-to-Head

Bigger by revenue
TLSI
TLSI
1.6× larger
TLSI
$13.2M
$8.2M
CPSH
Growing faster (revenue YoY)
TLSI
TLSI
+21.5% gap
TLSI
59.8%
38.3%
CPSH
Higher net margin
CPSH
CPSH
74.0% more per $
CPSH
0.2%
-73.9%
TLSI
More free cash flow
CPSH
CPSH
$2.0M more FCF
CPSH
$-487.0K
$-2.5M
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
17.8%
CPSH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPSH
CPSH
TLSI
TLSI
Revenue
$8.2M
$13.2M
Net Profit
$12.6K
$-9.8M
Gross Margin
14.9%
86.7%
Operating Margin
-1.2%
-24.8%
Net Margin
0.2%
-73.9%
Revenue YoY
38.3%
59.8%
Net Profit YoY
101.3%
3.5%
EPS (diluted)
$0.00
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPSH
CPSH
TLSI
TLSI
Q4 25
$8.2M
$13.2M
Q3 25
$8.8M
$11.6M
Q2 25
$8.1M
$11.2M
Q1 25
$7.5M
$9.2M
Q4 24
$5.9M
$8.3M
Q3 24
$4.2M
$7.3M
Q2 24
$5.0M
$7.4M
Q1 24
$5.9M
$6.5M
Net Profit
CPSH
CPSH
TLSI
TLSI
Q4 25
$12.6K
$-9.8M
Q3 25
$208.0K
$-10.8M
Q2 25
$103.8K
$-8.3M
Q1 25
$96.0K
$-10.4M
Q4 24
$-995.2K
$-10.1M
Q3 24
$-1.0M
$-2.4M
Q2 24
$-954.3K
$-4.3M
Q1 24
$-143.2K
$-13.2M
Gross Margin
CPSH
CPSH
TLSI
TLSI
Q4 25
14.9%
86.7%
Q3 25
17.1%
83.5%
Q2 25
16.5%
83.9%
Q1 25
16.4%
83.7%
Q4 24
-4.6%
85.3%
Q3 24
-12.3%
86.3%
Q2 24
-4.6%
87.6%
Q1 24
15.3%
85.0%
Operating Margin
CPSH
CPSH
TLSI
TLSI
Q4 25
-1.2%
-24.8%
Q3 25
3.1%
-77.9%
Q2 25
1.7%
-65.4%
Q1 25
1.7%
-79.9%
Q4 24
-22.2%
-91.8%
Q3 24
-35.0%
-118.9%
Q2 24
-26.1%
-111.0%
Q1 24
-4.4%
-180.8%
Net Margin
CPSH
CPSH
TLSI
TLSI
Q4 25
0.2%
-73.9%
Q3 25
2.4%
-93.5%
Q2 25
1.3%
-73.9%
Q1 25
1.3%
-113.2%
Q4 24
-16.8%
-122.4%
Q3 24
-24.6%
-32.6%
Q2 24
-19.0%
-58.8%
Q1 24
-2.4%
-204.5%
EPS (diluted)
CPSH
CPSH
TLSI
TLSI
Q4 25
$0.00
$-0.22
Q3 25
$0.01
$-0.96
Q2 25
$0.01
$-0.27
Q1 25
$0.01
$-0.39
Q4 24
$-0.07
$-0.38
Q3 24
$-0.07
$-0.12
Q2 24
$-0.07
$-0.21
Q1 24
$-0.01
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPSH
CPSH
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$13.2M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$24.6M
$-33.9M
Total Assets
$29.5M
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPSH
CPSH
TLSI
TLSI
Q4 25
$13.2M
$20.4M
Q3 25
$4.3M
$22.7M
Q2 25
$3.4M
$26.5M
Q1 25
$3.0M
$13.0M
Q4 24
$4.3M
$8.5M
Q3 24
$5.7M
$11.3M
Q2 24
$7.1M
$16.5M
Q1 24
$8.7M
$4.0M
Total Debt
CPSH
CPSH
TLSI
TLSI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$8.1K
Q3 24
$20.1K
Q2 24
$31.9K
Q1 24
$43.5K
Stockholders' Equity
CPSH
CPSH
TLSI
TLSI
Q4 25
$24.6M
$-33.9M
Q3 25
$15.1M
$-26.7M
Q2 25
$14.9M
$-19.4M
Q1 25
$14.7M
$-34.4M
Q4 24
$14.5M
$-25.9M
Q3 24
$15.4M
$-20.4M
Q2 24
$16.4M
$-25.3M
Q1 24
$17.3M
$-36.0M
Total Assets
CPSH
CPSH
TLSI
TLSI
Q4 25
$29.5M
$35.3M
Q3 25
$20.4M
$36.5M
Q2 25
$19.4M
$41.3M
Q1 25
$19.2M
$28.6M
Q4 24
$18.9M
$24.0M
Q3 24
$19.2M
$27.5M
Q2 24
$20.1M
$32.4M
Q1 24
$21.2M
$17.9M
Debt / Equity
CPSH
CPSH
TLSI
TLSI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPSH
CPSH
TLSI
TLSI
Operating Cash FlowLast quarter
$243.6K
$-2.5M
Free Cash FlowOCF − Capex
$-487.0K
$-2.5M
FCF MarginFCF / Revenue
-5.9%
-19.1%
Capex IntensityCapex / Revenue
8.9%
0.3%
Cash ConversionOCF / Net Profit
19.34×
TTM Free Cash FlowTrailing 4 quarters
$-479.6K
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPSH
CPSH
TLSI
TLSI
Q4 25
$243.6K
$-2.5M
Q3 25
$1.1M
$-3.7M
Q2 25
$649.3K
$-7.3M
Q1 25
$-1.3M
$-4.5M
Q4 24
$-3.5M
$-5.7M
Q3 24
$-1.2M
$-10.8M
Q2 24
$-1.0M
$-13.4M
Q1 24
$128.9K
$-10.9M
Free Cash Flow
CPSH
CPSH
TLSI
TLSI
Q4 25
$-487.0K
$-2.5M
Q3 25
$876.8K
$-3.9M
Q2 25
$476.4K
$-7.4M
Q1 25
$-1.3M
$-5.3M
Q4 24
$-4.5M
$-5.8M
Q3 24
$-1.3M
$-11.0M
Q2 24
$-1.6M
$-13.5M
Q1 24
$-134.5K
$-10.9M
FCF Margin
CPSH
CPSH
TLSI
TLSI
Q4 25
-5.9%
-19.1%
Q3 25
10.0%
-33.9%
Q2 25
5.9%
-66.1%
Q1 25
-17.9%
-57.3%
Q4 24
-75.3%
-69.7%
Q3 24
-29.8%
-149.9%
Q2 24
-31.8%
-183.1%
Q1 24
-2.3%
-169.3%
Capex Intensity
CPSH
CPSH
TLSI
TLSI
Q4 25
8.9%
0.3%
Q3 25
2.0%
1.9%
Q2 25
2.1%
0.8%
Q1 25
1.2%
8.2%
Q4 24
16.8%
0.6%
Q3 24
1.9%
2.3%
Q2 24
11.0%
0.8%
Q1 24
4.5%
1.0%
Cash Conversion
CPSH
CPSH
TLSI
TLSI
Q4 25
19.34×
Q3 25
5.05×
Q2 25
6.25×
Q1 25
-13.05×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons